Cochrane Database of Systematic Reviews
Prim Care 43(1):8395 viiiix Massie DC, Amaro A, Kaplan M (2022) Patient well-being and the clinical and economic burdens associated with obesity in the united States
While pharmacological tolerance is not well-established with GLP-1 receptor agonists, patients may experience varying degrees of appetite suppression over time
The drug is highly effective but can cause weight gain, muscle wasting, and other serious side effects
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, et al
The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: results from the LEADER trial